Characterization of human adipose-derived stem cells cultured in autologous serum after subsequent passaging and long term cryopreservation

Journal of Stem Cells

Volumn 9, Issue 3, 2014, Pages 135-148

  Bogdanova, Ance ^a   Berzins, Uldis ^a   Nikulshin, Sergey ^b   Skrastina, Dace ^a   Ezerta, Agnese ^a   Legzdina, Diana ^a   Kozlovska, Tatjana ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

Author keywords

Autologous serum; Human adipose derived stem cells; Multi color flow cytometry; Multilineage differentiation; Stem cell immunosuppression; Stem cell phenotype

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL SURFACE MARKER; ENDOGLIN; HERMES ANTIGEN; HLA DR ANTIGEN; THY 1 ANTIGEN; BIOLOGICAL MARKER;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; AUTOLOGOUS SERUM; CELL DIFFERENTIATION; CELL POPULATION; CHONDROCYTE; COCULTURE; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SERUM; STEM CELL CULTURE; ADIPOSE TISSUE; CARTILAGE CELL; CELL COMMUNICATION; CELL CULTURE; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CYTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PHENOTYPE; REGENERATIVE MEDICINE; TIME;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; CHONDROCYTES; COCULTURE TECHNIQUES; CRYOPRESERVATION; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES, MONONUCLEAR; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; SERUM; TIME FACTORS;

EID: 84907419587     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Zuk, PA; Zhu, M; Mizuno, H; Huang, J; Futrell, JW; Katz, AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng, 2001, 7:211-26.
2. Kern, S; Eichler, H; Stoeve, J; Klüter, H; Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord, or adipose tissue. Stem Cells, 2006, 24:1294-1301.
3. Jeon, ES; Moon, HJ; Lee, MJ; Song, HY; Kim, YM; Bae, YC, et al. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-β-dependent mechanism. J Cell Sci, 2006, 119:4994–5005.
4. Zuk, PA; Zhu, M; Ashjian, P; De Ugarte, DA; Huang, JI; Mizuno, H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell, 2002, 13:4279-95.
5. Lee, JH; Kemp, DM. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun, 2006, 341:882-88.
6. Planat-Bénard, V; Menard, C; André, M; Puceat, M; Perez, A; Garcia-Verdugo, JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res, 2004, 94:223-29.
7. Jang, S; Cho, HH; Cho, YB; Park, JS; Jeong, HS. Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol, 2010, 11:25. doi:10.1186/1471-2121-11-25.
8. Cao, Y; Sun, Z; Liao, L; Meng, Y; Han, Q; Zhao, RC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun, 2005, 332:370-79.
9. Taléns-Visconti, R; Bonora, A; Jover, R; Mirabet, V; Carbonell, F; Castell, JV, et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol, 2006, 12:5834-45.
10. Chandra, V; Swetha, G; Muthyala, S; Jaiswal, AK; Bellare, JR; Nair, PD, et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PloS ONE, 2011, 6(6):e20615. doi:10.1371/journal.pone.0020615.
11. Rodriguez, AM; Elabd, C; Amri, EZ; Ailhaud, G; Dani, C. The human adipose tissue is a source of multipotent stem cells. Biochimie, 2005, 87:125-28.
12. Kakudo, N; Shimotsuma, A; Kusumoto, K. Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun, 2007, 359:239-44.
13. Fraser, JK; Wulur, I; Alfonso, Z; Hedrick, MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol, 2006, 24:150-54.
14. Dominici, M; Le Blanc, K; Mueller, I; Slaper-Cortenbach, I; Marini, FC; Krause, DS; et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006, 8:315-17.
15. Schäffler, A; Büchler, C. Concise review: adipose tissue-derived stromal cells – basic and clinical implications for novel cell-based therapies. Stem Cells, 2007, 25:818-27.
16. De Rosa, SC; Brenchley, JM; Roederer, M. Beyond six colors: a new era in flow cytometry. Nat Med, 2003, 9:112-17.
17. Bartholomew, A; Sturgeon, C; Siatskas, M; Ferrer, K; McIntosh, K; Patil, S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30:42-48.
18. Di Nicola, M; Carlo-Stella, C; Magni, M; Milanesi, M; Longoni, PD; Matteucci, P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99:3838-43.
19. Le Blanc, K; Tammik, L; Sundberg, B; Haynesworth, SE; Ringdén, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol, 2003, 57:11-20.
20. Tse, WT; Pendleton, JD; Beyer, WM; Egalka, MC; Giunan, EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 2003, 75:389-97.
21. Aggarwal, S; Pittenger, MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105:1815-22.
22. Cui, L; Yin, S; Liu, W; Li, N; Zhang, W; Cao, Y. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng, 2007, 13:1185-95.
23. Meisel, R; Zibert, A; Laryea, M; Göbel, U; Däubener, W; Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood, 2004, 103:4619-21.
24. Chabannes, D; Hill, M; Merieau, E; Rossignol, J; Brion, R; Soulillou, P, et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood, 2007, 110:3691-94.
25. Sato, K; Ozaki, K; Oh, I; Meguro, A; Hatanaka, K; Nagai, T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, 2007, 109:228-34.
26. Abumaree, M; Al Jumah, M; Pace, RA; Kalionis, B. Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev, 2012, 8:375-92.
27. De Miguel, MP; Fuentes-Julián, S; Blázquez-Martínez, A; Pascual, CY; Aller, MA; Arias, J, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med, 2012, 12:574-91.
28. Glennie, S; Soeiro, I; Dyson, PJ; Lam, E; Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 2005, 105:2821-27.
29. Djouad, F; Plence, P; Bony, C; Tropel, P; Apparailly, F; Sany, J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102:3837-44.
30. Beyth, S; Borovsky, Z; Mevorach, D; Liebergall, M; Gazit, Z; Aslan, H, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 2005, 105:2214-19.
31. Rasmusson, I; Ringdén, O; Sundberg, B; Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003, 76:1208-13.
32. Corcione, A; Benvenuto, F; Ferretti, E; Giunti, D; Cappiello, V; Cazzanti, F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107:367-72.
33. Doerr, HW; Cinatl, J; Stürmer, M; Rabenau, HF. Prions and orthopedic surgery. Infection, 2003, 31:163-71.
34. Spees, JL; Gregory, CA; Singh, H; Tucker, HA; Peister, A; Lynch, PJ, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther, 2004, 9:747-56.
35. Bogdanova, A; Berzins, U; Bruvere, R; Kozlovska, T. Adipose-derived stem cells cultured in autologous serum maintain the characteristics of mesenchymal stem cells. Proc Latv Acad Sci., Sect B, Nat Exact Appl Sci, 2010, 64:106-13.
36. Stute, N; Holtz, K; Bubenheim, M; Lange, C; Blake, F; Zander, AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol, 2004, 32:1212-25.
37. Shahdadfar, A; Frønsdal, K; Haug, T; Reinholt, FP; Brinchmann, JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 2005, 23:1357-66.
38. Secco, M; Zucconi, E; Vieira, NM; Fogaça, LLQ; Cerqueira, A; Carvalho, MDF, et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 2008, 26:146-50.
39. Gronthos, S; Franklin, DM; Leddy, HA; Robey, PG; Storms, RW; Gimble, JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol, 2001, 189:54-63.
40. Katz, AJ; Tholpady, A; Tholpady, SS; Shang, H; Ogle, RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells, 2005, 23:412-23.
41. Mitchell, JB; McIntosh, K; Zvonic, S; Garrett, S; Floyd, ZE; Kloster, A, et al. Immunophenotype of human adipose-derived cells: temporal change in stromalassociated and stem cell–associated markers. Stem Cells, 2006, 24:376-85.
42. Astori, G; Vignati, F; Bardelli, S; Tubio, M; Gola, M; Albertini, V, et al. "In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J Transl Med, 2007, 5:55.
43. Varma, MJO; Breuls, RGM; Schouten, TE; Jurgens, WJFM; Bontkes, HJ; Schuurhuis, GJ; et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev, 2007, 16:91-104.
44. Zhu, Y; Liu, T; Song, K; Fan, X; Ma, X; Cui, Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct, 2008, 26:664-75.
45. Park, E; Patel, AN. Changes in the expression pattern of mesenchymal and pluripotent markers in human adipose-derived stem cells. Cell Biol Int, 2010, 34:979-84.
46. Yang, XF; He, X; He, J; Zhang, LH; Su, XJ; Dong, ZY, et al. High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. J Biomed Sci, 2011, 18:59. doi:10.1186/1423-0127-18-59.
47. Baer, PC; Kuçi, S; Krause, M; Kuçi, Z; Zielen, S; Geiger, H, et al. Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology. Stem Cells Dev, 2013, 22:330-39.
48. Lin, K; Matsubara, Y; Masuda, Y; Togashi, K; Ohno, T; Tamura, T, et al. Characterization of adipose tissuederived cells isolated with the Celution system. Cytotherapy, 2008, 10:417-26.
49. Martins, AA; Paiva, A; Morgado, JM; Gomes, A; Pais, ML. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc, 2009, 41:943-46.
50. Mizuno, N; Shiba, H; Ozeki, Y; Mouri, Y; Niitani, M; Inui, T, et al. Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int, 2006, 30:521-24.
51. Nimura, A; Muneta, T; Koga, H; Mochizuki, T; Suzuki, K; Makino, H, et al. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum. Comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum, 2008, 58:501–10.
52. Im, W; Chung, J; Kim, SH; Kim, M. Efficacy of autologous serum in human adipose-derived stem cells; cell markers, growth factors and differentiation. Cell Mol Biol (Noisy-le-grand), 2011, 57. Suppl:OL1470-5.
53. Dahl, JA; Duggal, S; Coulston, N; Millar, D; Melki, J; Shahdadfar, A, et al. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol, 2008, 52:1033-42.
54. Festy, F; Hoareau, L; Bes-Houtmann, S; Péquin, AM; Gonthier, MP; Munstun, A, et al. Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes. Histochem Cell Biol, 2005, 124:113-21.
55. Chamberlain, G; Fox, J; Ashton, B; Middleton, J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 2007, 25:2739-49.
56. Wall, ME; Bernacki, SH; Loboa, EG. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal ste cells. Tissue Eng, 2007, 13:1291-98.
57. Gruber, HE; Somayaji, S; Riley, F; Hoelscher, GL; Norton, HJ; Ingram, J, et al. Human adipose-derived mesenchymal stem cells: serial passaging, doubling time and cell senescence. Biotech Histochem, 2012, 87:303-11.
58. Yañez, R; Lamana, ML; García-Castro, J; Colmenero, I; Ramírez, M; Bueren, JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells, 2006, 24:2582-91.
59. Samuelsson, H; Ringdén, O; Lönnies, H; Le Blanc, K. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy, 2009, 11:129-36.
60. Auletta, JJ; Zale, EA; Welter, JF; Solchaga, LA. Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential. Stem Cells Int, 2001, 235176. doi:10.4061/2011/235176.
61. Capra, E; Beretta, R; Parazzi, V; Viganò, M; Lazzari, L; Baldi, A, et al. Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages. Proteome Sci, 2012, 10:46. doi:10.1186/1477-5956-10-46.
62. González-Cruz, RD; Darling, EM. Adipose-derived stem cell fate is predicted by cellular mechanical properties. Adipocyte, 2013, 2:87-91.